TLSI Q4 2021 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M

Gross Profit

$3M98.7% margin

Operating Income

-$6M-247.0% margin

Net Income

-$7M-271.3% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$680,921

Free Cash Flow

-$680,920

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$38M

Total Liabilities

$7M

Stockholders' Equity

$31M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$3M	$0	—
Operating Income	-$6M	-$108,493	-5740.9%
Net Income	-$7M	-$105,195	-6517.2%